Depression and incident alopecia areata and atopic dermatitis: A prospective cohort study Authors: Dan Wang, Weisong Luo, Peizhi Deng, Yuzhou Huang, Jianyun Lu Published: 2026 To the Editor: Alopecia areata (AA) and atopic dermatitis (AD) are common chronic inflammatory skin diseases with substantial clinical and psychosocial burden.1,2 Depression is frequently observed in both conditions,3,4 yet prospective evidence integrating genetic susceptibility and inflammatory pathways remains limited. We examined whether baseline depression was associated with incident AA and AD in the UK Biobank and explored roles of genetic susceptibility and inflammatory markers. Depression, AA, and AD were ascertained using linked health records. Cox proportional hazards models estimated adjusted hazard ratios (HRs). Polygenic risk scores (PRSs) for AA and AD were derived from published genome-wide association studies (Supplementary Tables I and II; Methods, available via Mendeley at https://data.mendeley.com/datasets/ck3mz5ym5f/1) and categorized into tertiles. Mediation analyses were performed for selected inflammatory factors. A negative-control outcome using kidney stones was conducted in the National Health and Nutrition Examination Survey. During a median follow-up of 13.4 years, 180 incident AA and 2896 incident AD cases were identified (Table Ⅰ). Depression was associated with higher risks of incident AA (HR, 1.83; 95% CI, 1.22-2.74) and AD (HR, 1.53; 95% CI, 1.36-1.71) (Supplementary Table Ⅲ, available via Mendeley at https://data.mendeley.com/datasets/ck3mz5ym5f/1). Estimates for AA varied across subgroups and should be interpreted cautiously given the limited number of cases. No consistent subgroup differences were observed for AD (Supplementary Table Ⅳ, available via Mendeley at https://data.mendeley.com/datasets/ck3mz5ym5f/1). Table IBaseline characteristics of participants according to depression statusBaseline characteristicsTotal participants (n = 416,983)DepressionPNo (n = 382535)Yes (n = 34448)Age (y), mean ± SD56.85 ± 8.0056.95 ± 8.0155.80 ± 7.77<.001Sex, n (%)<.001 Female225,362 (54.05)202,788 (53.01)22,574 (65.53) Male191,621 (45.95)179,747 (46.99)11,874 (34.47)Average total household income before tax (€), n (%)<.001 <18,00080,044 (19.20)70,050 (18.31)9994 (29.01) 18,000-30,99992,521 (22.19)84,629 (22.12)7892 (22.91) 31,000-51,99994,895 (22.76)87,906 (22.98)6989 (20.29) 52,000-100,00073,436 (17.61)69,174 (18.08)4262 (12.37) >100,00019,147 (4.59)18,276 (4.78)871 (2.53) Unknown56,940 (13.66)52,500 (13.72)4440 (12.89)Education, n (%)<.001 College or university degree129,489 (31.05)119,265 (31.18)10,224 (29.68) Professional qualifications116,654 (27.98)107,122 (28.00)9532 (27.67) A levels/AS levels or equivalent22,282 (5.34)20,358 (5.32)1924 (5.59) O levels/GCSEs or equivalent72,224 (17.32)66,231 (17.31)5993 (17.40) None of the above72,810 (17.46)66,306 (17.33)6504 (18.88) Missing data3524 (0.85)3253 (0.85)271 (0.79)Alcohol status<.001 Current drinking389,325 (93.37)358,726 (93.78)30,599 (88.83) Noncurrent drinking27,301 (6.55)23,521 (6.15)3780 (10.97) Missing data357 (0.08)288 (0.07)69 (0.20)Smoking<.001 Current smoker42,345 (10.16)37,004 (9.67)5341 (15.50) Noncurrent smoker373,179 (89.50)344,175 (89.97)29,004 (84.20) Missing data1459 (0.34)1356 (0.36)103 (0.30)Townsend index, mean ± SD−1.54 ± 2.94−1.59 ± 2.91−0.98 ± 3.22<.001BMI (kg/m2), mean ± SD27.41 ± 4.7627.33 ± 4.6828.25 ± 5.47<.001MET, min/wk2665.30 ± 2659.992684.70 ± 2663.872442.31 ± 2604.73<.001Alopecia areata<.001 Yes180 (0.04)151 (0.04)29 (0.08) No416,803 (99.96)382,384 (99.96)34,419 (99.92)Atopic dermatitis<.001 Yes2896 (0.69)2548 (0.67)348 (1.01) No414,087 (99.31)379,987 (99.33)34,100 (98.99)BMI, Body mass index; SD, standard deviation; MET, Metabolic Equivalent of Task. Baseline characteristics of participants according to depression status BMI, Body mass index; SD, standard deviation; MET, Metabolic Equivalent of Task. Higher genetic risk was associated with increased risks of AA and AD (Supplementary Table Ⅴ, available via Mendeley at https://data.mendeley.com/datasets/ck3mz5ym5f/1). Participants with both depression and high PRS had higher risks of AA (HR, 2.36; 95% CI, 1.18-4.73) and AD (HR, 2.24; 95% CI, 1.87-2.67), compared with those with no depression and low PRS. A gradient across PRS strata was observed, particularly for AD (Fig 1; Supplementary Table Ⅵ, available via Mendeley at https://data.mendeley.com/datasets/ck3mz5ym5f/1). Interactions between depression and PRS were significant (P-interaction = .001 for AA; <.001 for AD). Eosinophil percentage showed a statistically detectable but small mediating effect, which should be interpreted cautiously and does not support a biologic mechanism (Supplementary Tables Ⅶ and Ⅷ; Figs 2 and 3, available via Mendeley at https://data.mendeley.com/datasets/ck3mz5ym5f/1). Results were unchanged after excluding events within the first year (Supplementary Table Ⅸ, available via Mendeley at https://data.mendeley.com/datasets/ck3mz5ym5f/1). In the negative-control analysis, depression was inversely associated with kidney stones (OR, 0.66; 95% CI, 0.49-0.89) (Supplementary Table X, available via Mendeley at https://data.mendeley.com/datasets/ck3mz5ym5f/1). Joint associations of baseline depression and genetic susceptibility with the risk of incident alopecia areata (AA) and atopic dermatitis (AD). Baseline depression was associated with increased risks of incident AA and AD. Joint associations with PRS were observed, although these findings should be considered exploratory and require further validation. The negative-control finding may not be fully explained by differences in health care utilization. However, this analysis does not fully exclude health care–seeking or ascertainment bias, given its use of National Health and Nutrition Examination Survey rather than UK Biobank, its cross-sectional design, and reliance on self-reported outcomes. Limitations include the small number of AA cases, baseline-only assessment of depression, and potential residual confounding. PRSs were based on a limited number of variants, categorized into tertiles, and lacked external validation, which may limit risk discrimination. The cohort was restricted to individuals of European ancestry. Mediation effects were small. In conclusion, depression was associated with increased risks of incident AA and AD. Findings related to genetic susceptibility and inflammatory markers are exploratory and require further validation. Declaration of generative AI and AI-assisted technologies in the writing process During the preparation of this work the authors used DeepSeek-V3.2 in order to improve readability and language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article. Conflicts of interest None disclosed. Footnotes Funding sources: This work was supported by the Natural Science Foundation of Hunan Province, China (2024JJ7627), Changsha Municipal Natural Science Foundation (No.kq2403056), Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University (YX202201), and the Hunan Provincial Natural Science Foundation (2023JJ30852). Patient consent: Consent for the publication of recognizable patient photographs or other identifiable material was obtained by the authors and included at the time of article submission to the journal stating that all patients gave consent with the understanding that this information may be publicly available. IRB approval status: Ethical approval was granted by the North West Multicenter Research Ethics Committee (11/NW/0382) and all participants provided written informed consent. The data in this research were available with permission via application number 224336. References